Friday, 10 February 2017


Aurobindo Pharma is down, dragging the Healthcare index alongwith it, and is contributing nearly 42% to the index's losses. The index is trading at 15210.87 level, down by 61.60 points or 0.40%.
  
On Thursday, Aurobindo Pharma had registered a 6.29% rise in its consolidated net profit at Rs 578.59 crore for Q3 as compared to Rs 544.31 crore (YoY).

Major stocks in the index are trading in red, where Aurobindo Pharma is down by 3.07%, Lincoln Pharma is down by 1.93%, Neuland Labs is down by 1.72%, Lupin is down by 1.36% and Jubilant Life Sciences is down by 1.32%.

Whereas, Alembic Ltd., is up by 9.68%, Vivimed Labs is up by 5.00%, SMS Pharma is up by 2.60%, Natco Pharma is up by 1.37% and Lyka Labs is up by 1.25%.

Aurobindo Pharma Ltd is currently trading at Rs 685.2, down by Rs 21.2 or 3% from its previous closing of Rs 706.4 on the BSE. The scrip opened at Rs 710 and has touched a high and low of Rs 710 and Rs 681 respectively. So far 2357092(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs 41336.38 crore.

The BSE group 'A' stock of face value Rs 1 has touched a 52 week high of Rs 895 on 06-Oct-2016 and a 52 week low of Rs 582 on 25-Feb-2016. Last one week high and low of the scrip stood at Rs 714.75 and Rs 671.1 respectively. The promoters holding in the company stood at 51.94 % while Institutions and Non-Institutions held 35.07 % and 13 % respectively. The stock is currently trading below its 200 DMA.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717

0 comments: